BNC Wealth Management LLC Lowers Holdings in Danaher Co. (NYSE:DHR)

BNC Wealth Management LLC reduced its stake in shares of Danaher Co. (NYSE:DHR) by 2.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,167 shares of the conglomerate’s stock after selling 125 shares during the quarter. BNC Wealth Management LLC’s holdings in Danaher were worth $1,159,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. nVerses Capital LLC purchased a new stake in Danaher during the second quarter worth $25,000. CarsonAllaria Wealth Management Ltd. acquired a new stake in shares of Danaher during the 2nd quarter valued at about $25,000. MFA Wealth Advisors LLC purchased a new position in shares of Danaher in the 2nd quarter valued at about $51,000. Financial Connections Group Inc. acquired a new position in Danaher in the 2nd quarter worth about $51,000. Finally, Western Pacific Wealth Management LP acquired a new position in Danaher in the 1st quarter worth about $55,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

DHR has been the subject of a number of recent analyst reports. KeyCorp boosted their price objective on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research report on Wednesday, October 23rd. Barclays reduced their price objective on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 23rd. Stephens reiterated an “overweight” rating and issued a $315.00 target price on shares of Danaher in a research report on Wednesday, October 23rd. Evercore ISI upped their price target on shares of Danaher from $275.00 to $278.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. Finally, UBS Group lowered their price objective on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a report on Wednesday, October 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $287.16.

Danaher Stock Performance

NYSE:DHR opened at $247.81 on Thursday. The firm has a market capitalization of $178.99 billion, a price-to-earnings ratio of 47.29, a PEG ratio of 4.55 and a beta of 0.85. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The company’s 50-day moving average is $265.79 and its two-hundred day moving average is $260.75. Danaher Co. has a 1-year low of $192.35 and a 1-year high of $281.70.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. During the same period in the prior year, the business posted $2.02 earnings per share. The firm’s revenue for the quarter was up 3.1% compared to the same quarter last year. Analysts forecast that Danaher Co. will post 7.51 EPS for the current year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were issued a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. Danaher’s payout ratio is 20.61%.

Insider Activity at Danaher

In other news, SVP Georgeann Couchara sold 952 shares of the company’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $268.37, for a total transaction of $255,488.24. Following the completion of the transaction, the senior vice president now directly owns 4,212 shares of the company’s stock, valued at approximately $1,130,374.44. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 10.90% of the stock is currently owned by corporate insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.